P3 Health Partners (PIIIW) Net Income towards Common Stockholders (2021 - 2025)

P3 Health Partners has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$165.7 million in Q4 2025.

• For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 28.31% year-over-year to -$165.7 million; the trailing twelve-month figure through Dec 2025 stood at -$323.1 million (down 4.09% YoY), and the FY2025 full-year result was -$323.1 million, down 4.09% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at -$165.7 million, down from -$69.5 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $564.4 million in Q4 2021, with the low at -$903.1 million in Q2 2022.
• Historically, Net Income towards Common Stockholders has averaged -$92.7 million across 5 years, with a median of -$46.9 million in 2024.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 2965.07% — and 2023, when it jumped 96.95%.
• P3 Health Partners' Net Income towards Common Stockholders stood at $564.4 million in 2021, then slumped by 194.32% to -$532.3 million in 2022, then surged by 87.02% to -$69.1 million in 2023, then sank by 86.88% to -$129.1 million in 2024, then retreated by 28.31% to -$165.7 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$165.7 million (Q4 2025), -$69.5 million (Q3 2025), and -$43.7 million (Q2 2025), per Business Quant data.